another thing why did they have to enter into another USD 750m...

First 83 Last

Share
Profile

Follow
scrabble1

5,726 Posts.

1763

25/06/24

10:41

Post #: 74474448
Share

Originally posted by scrabble1 ↑

I don’t have much idea when it comes to charts but from a fundamental perspective I said last week on here that MIN was in a stronger position when it launched a takeover offer for AGO and explained why.

Nearly all of their debt is in USD and the AUD has weakened 200 basis points since Dec 31. The AUD value of their USD debt has increased $150m to about $4.6b using rate of 0.664. The interest cost alone will be close to $200m for this HY, well up on last HY. This doesn’t take into account the additional debt and interest costs it will have taken on in this HY due to cap commitments, sustaining investments and potential ebitda losses on some projects.

there will be considerable rehabilitation costs for yilgRn. There will be a provision and potential write down of assets. Ironically this IO projects has fetched about USD 5 more on avg than their other IO project over the last few quarters. Yes costs are higher for yilgarn but not substantially. Utah’s margins would be well down on the last HY.

then there will be write down on other assets it holds such as delta lithium ltd. This was valued at $77m as at Dec 31. Lithium is well down in this HY and the decline has accelerated over the last month

Onslow is still a while away from achieving anywhere near max run rate output. Until then the costs will be amortised over a lower amount of shipments. Its net debt was substantial as at 31 Dec with a payback of many years.

The $1.3b sale value has yet to be finalised and will not be done until 2nd half of yr assuming finalisation of project conditions are met. It entered into new $750m USD facility on 5 June as a result. $200m will be deferred in any case untik prod target met and $100m chewed up in taxes. Then there’s more money they paid for bci assets and an other $200m instalment they are paying on 1 July for Onslow. P/E ratio currently is insane also

Its fin position whej it tried to take over ago was substantially better than now.

Expand

another thing why did they have to enter into another USD 750m facility this month? Didn’t they have a 400m undrawn facility at the beginning of the year which they said in the hy report was sufficient. Did they max that out already?

MIN Price at posting: $55.43 Sentiment: None Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

OCC

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

SPR

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

SRL

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

MSB

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

PL3

Patagonia looks to raise $2.15M for South American exploration and development

There are more pages in this discussion • 53 more messages in this thread...

First 83 Last

Add MIN (ASX) to my watchlist

(20min delay)
Last $56.32		Change -0.010(0.02%)		Mkt cap ! $11.06B

Open	High	Low	Value	Volume
$56.90	$57.57	$56.16	$38.01M	671.8K

Buyers (Bids)

No.	Vol.	Price($)
3	3152	$56.31

Sellers (Offers)

Price($)	Vol.	No.
$56.38	2164	1

View Market Depth

No.	Vol.	Price($)
2	2820	56.310
3	1900	56.300
2	391	56.290
1	40	56.280
1	100	56.250

Price($)	Vol.	No.
56.450	850	1
56.480	30	1
56.500	850	1
56.520	850	1
56.550	850	1

Last trade - 16.10pm 09/07/2024 (20 minute delay)

MIN (ASX) Chart

another thing why did they have to enter into another USD 750m...

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Patagonia looks to raise $2.15M for South American exploration and development

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

another thing why did they have to enter into another USD 750m...

Top Stories

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Patagonia looks to raise $2.15M for South American exploration and development

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News